Business Description
Orgenesis Inc
NAICS : 325412
SIC : 2834
ISIN : US68619K3032
Description
Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Octomera and Therapies. The company's therapies pipeline includes Immuno-Oncology, Viral Diseases, Metabolic & Autoimmune Diseases, Vascular & Musculoskeletal Diseases, and Kidney Disease.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.73 | |||||
9-Day RSI | 48.6 | |||||
14-Day RSI | 49.58 | |||||
3-1 Month Momentum % | 209.38 | |||||
6-1 Month Momentum % | 230 | |||||
12-1 Month Momentum % | -64.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -1675.27 | |||||
OCF Margin % | -1649.86 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -0.44 | |||||
EV-to-EBITDA | -0.46 | |||||
EV-to-Revenue | 19.08 | |||||
EV-to-Forward-Revenue | 3.03 | |||||
EV-to-FCF | -1.14 | |||||
Earnings Yield (Greenblatt) % | -227.27 | |||||
FCF Yield % | -1105.8 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ORGS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Orgenesis Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.035 | ||
| EPS (TTM) ($) | -11.51 | ||
| Beta | 1.1696 | ||
| 3-Year Sharpe Ratio | 0.6 | ||
| 3-Year Sortino Ratio | 13.51 | ||
| Volatility % | 4444.01 | ||
| 14-Day RSI | 49.58 | ||
| 14-Day ATR ($) | 0.133744 | ||
| 20-Day SMA ($) | 0.411778 | ||
| 12-1 Month Momentum % | -64.92 | ||
| 52-Week Range ($) | 0.0001 - 1.41 | ||
| Shares Outstanding (Mil) | 9.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Orgenesis Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Orgenesis Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-09 | In 123 days | ||
| Second quarter earnings results for 2026 | 2026-08-10 | In 32 days | ||
| General meeting for 2025 | 2026-07-31 | In 22 days | ||
| First quarter earnings results for 2026 | 2026-07-17 | In 8 days | ||
| Annual report for 2024 | 2026-03-26 | 0.21 (-16.00%) | ||
| Third quarter earnings results for 2024 | 2024-11-13 | 1.20 (+7.14%) | ||
| 0.1:1 Stock Split | 2024-09-25 | 3.98 (-1.70%) | ||
| Second quarter earnings results for 2024 | 2024-08-08 | 7.08 (-11.46%) | ||
| 0.083333:1 Stock Split | 2017-11-16 | 30.00 (-7.44%) | ||
| 35:1 Stock Split | 2011-09-02 | 0.45 (+0.00%) |
Show
Entries
Orgenesis Inc Frequently Asked Questions
What is Orgenesis Inc(ORGS)'s stock price today?
The current price of ORGS is $0.16. The 52 week high of ORGS is $1.41 and 52 week low is $0.00.
When is next earnings date of Orgenesis Inc(ORGS)?
The next earnings date of Orgenesis Inc(ORGS) is 2026-07-17 Est..
Does Orgenesis Inc(ORGS) pay dividends? If so, how much?
Orgenesis Inc(ORGS) does not pay dividend.
Guru Commentaries on OTCPK:ORGS
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| SRAX Announces Launch of Video Virtual Roadshow Feature into Investor Communications Platform, SRAX IR | 2020-03-31 |
Articles on Orgenesis Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers